GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Sabra Health Care REIT Inc (NAS:SBRA) » Definitions » Peter Lynch Fair Value
中文

Sabra Health Care REIT (Sabra Health Care REIT) Peter Lynch Fair Value

: N/A (As of Today)
View and export this data going back to 2010. Start your Free Trial

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Sabra Health Care REIT's Peter Lynch Fair Value or its related term are showing as below:


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Sabra Health Care REIT was 3.09. The lowest was 1.97. And the median was 2.33.


SBRA's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the REITs industry.
Industry Median: 1.21
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Sabra Health Care REIT Peter Lynch Fair Value Historical Data

The historical data trend for Sabra Health Care REIT's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sabra Health Care REIT Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sabra Health Care REIT Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sabra Health Care REIT Price-to-Peter-Lynch-Fair-Value Distribution

For the REITs industry and Real Estate sector, Sabra Health Care REIT's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Sabra Health Care REIT's Price-to-Peter-Lynch-Fair-Value falls into.



Sabra Health Care REIT Peter Lynch Fair Value Calculation

Sabra Health Care REIT's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *0.378
=N/A

Sabra Health Care REIT's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.38.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Sabra Health Care REIT  (NAS:SBRA) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Sabra Health Care REIT's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=13.77/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sabra Health Care REIT Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Sabra Health Care REIT's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sabra Health Care REIT (Sabra Health Care REIT) Business Description

Traded in Other Exchanges
Address
18500 Von Karman Avenue, Suite 550, Irvine, CA, USA, 92612
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities. The company considers merger and acquisition investment as a component of its operational growth strategy. Sabra works with existing operators to identify strategic development opportunities.
Executives
Michael Lourenco Costa officer: Executive VP & CAO 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Catherine Cusack director 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Andrews Harold W. Jr. officer: Executive VP, CFO & Secretary C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612
Michael J Foster director 36 GROVE STREET, NEW CANAAN CT 06840
Ann Kono director 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Porter Clifton J Ii director 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Robert A. Ettl director C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612
Richard K Matros director, officer: CEO and President
Raymond J Lewis director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Lynne S Katzmann director 18500 VON KARMAN AVENUE,SUITE 550, IRVINE CA 92612
Milton J Walters director C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Ronald G Geary director 10140 LINN STATION RD, LOUISVILLE KY 40223-3813
Jeffrey A. Malehorn director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Talya Nevo-hacohen officer: Executive VP, CIO & Treasurer C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612
Craig A. Barbarosh director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305